Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

15.40
-0.5000-3.14%
Volume:1.19M
Turnover:18.46M
Market Cap:1.84B
PE:-14.80
High:15.96
Open:15.95
Low:15.24
Close:15.90
Loading ...
Mar 26, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 09, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 08, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Major Issues Report

8-K - Current report
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report
Jan 15, 2021

Major Issues Report

8-K - Current report
Nov 23, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2020

Major Issues Report

8-K - Current report
Nov 04, 2020

Major Issues Report

8-K - Current report
Oct 07, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 06, 2020

Major Issues Report

8-K - Current report
Oct 06, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 29, 2020

Correspondence

CORRESP [Cover] - Correspondence